Bank of Nova Scotia’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11,505
Closed -$1.86M 1231
2021
Q4
$1.86M Buy
11,505
+1,885
+20% +$305K ﹤0.01% 905
2021
Q3
$1.6M Buy
+9,620
New +$1.64M ﹤0.01% 886

Other funds holding FBT

Bank of Nova Scotia's FBT Position: Q1 2022 in Review

Bank of Nova Scotia sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2022, closing a stake of 11,505 shares — an estimated $1.86M sold.

Bank of Nova Scotia first reported a position in FBT in Q3 2021 and held it in 2 quarters. The position peaked at $1.86M in Q4 2021. 220 funds tracked by Wall St. Rank hold FBT as of Q1 2022.

  • Bank of Nova Scotia reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2022 after selling out during the quarter.
  • Bank of Nova Scotia sold 11,505 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2022, an estimated $1.86M.
  • Bank of Nova Scotia first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2021 and held it in 2 quarters.
  • Bank of Nova Scotia's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.86M in Q4 2021.
  • 220 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2022.

Based on Bank of Nova Scotia's 13F filing for Q1 2022, filed 9 May 2022.